Zimmer Biomet Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $121.31
- Today's High:
- $122.98
- Open Price:
- $122.42
- 52W Low:
- $102.0411
- 52W High:
- $149.0022
- Prev. Close:
- $122.44
- Volume:
- 900265
Company Statistics
- Market Cap.:
- $25.59 billion
- Book Value:
- 59.25
- Revenue TTM:
- $7.20 billion
- Operating Margin TTM:
- 19.88%
- Gross Profit TTM:
- $4.92 billion
- Profit Margin:
- 7.03%
- Return on Assets TTM:
- 4.18%
- Return on Equity TTM:
- 4.14%
Company Profile
Zimmer Biomet Holdings Inc had its IPO on 2001-07-25 under the ticker symbol ZBH.
The company operates in the Healthcare sector and Medical Devices industry. Zimmer Biomet Holdings Inc has a staff strength of 18,000 employees.
Stock update
Shares of Zimmer Biomet Holdings Inc opened at $122.42 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $121.31 - $122.98, and closed at $121.43.
This is a -0.82% slip from the previous day's closing price.
A total volume of 900,265 shares were traded at the close of the day’s session.
In the last one week, shares of Zimmer Biomet Holdings Inc have increased by +1.66%.
Zimmer Biomet Holdings Inc's Key Ratios
Zimmer Biomet Holdings Inc has a market cap of $25.59 billion, indicating a price to book ratio of 2.1978 and a price to sales ratio of 3.3093.
In the last 12-months Zimmer Biomet Holdings Inc’s revenue was $7.20 billion with a gross profit of $4.92 billion and an EBITDA of $2.36 billion. The EBITDA ratio measures Zimmer Biomet Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Zimmer Biomet Holdings Inc’s operating margin was 19.88% while its return on assets stood at 4.18% with a return of equity of 4.14%.
In Q2, Zimmer Biomet Holdings Inc’s quarterly earnings growth was a positive 37% while revenue growth was a positive 4.9%.
Zimmer Biomet Holdings Inc’s PE and PEG Ratio
- Forward PE
- 18.2815
- Trailing PE
- 51.0167
- PEG
- 1.0781
Its diluted EPS in the last 12-months stands at $2.4 per share while it has a forward price to earnings multiple of 18.2815 and a PEG multiple of 1.0781. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zimmer Biomet Holdings Inc’s profitability.
Zimmer Biomet Holdings Inc stock is trading at a EV to sales ratio of 4.0831 and a EV to EBITDA ratio of 20.8723. Its price to sales ratio in the trailing 12-months stood at 3.3093.
Zimmer Biomet Holdings Inc stock pays annual dividends of $0.96 per share, indicating a yield of 0.8% and a payout ratio of 13.39%.
Balance sheet and cash flow metrics
- Total Assets
- $21.29 billion
- Total Liabilities
- $2.23 billion
- Operating Cash Flow
- $-392500000.00
- Capital Expenditure
- $170.60 million
- Dividend Payout Ratio
- 13.39%
Zimmer Biomet Holdings Inc ended 2024 with $21.29 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $21.29 billion while shareholder equity stood at $12.38 billion.
Zimmer Biomet Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $2.23 billion in other current liabilities, 3200000.00 in common stock, $9.90 billion in retained earnings and $8.74 billion in goodwill. Its cash balance stood at $319.80 million and cash and short-term investments were $319.80 million. The company’s total short-term debt was $520,000,000 while long-term debt stood at $5.19 billion.
Zimmer Biomet Holdings Inc’s total current assets stands at $4.39 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.37 billion compared to accounts payable of $354.60 million and inventory worth $2.28 billion.
In 2024, Zimmer Biomet Holdings Inc's operating cash flow was $-392500000.00 while its capital expenditure stood at $170.60 million.
Comparatively, Zimmer Biomet Holdings Inc paid $0.13 in dividends in 2024.
Other key metrics
- Current Trading Price
- $121.43
- 52-Week High
- $149.0022
- 52-Week Low
- $102.0411
- Analyst Target Price
- $150.15
Zimmer Biomet Holdings Inc stock is currently trading at $121.43 per share. It touched a 52-week high of $149.0022 and a 52-week low of $149.0022. Analysts tracking the stock have a 12-month average target price of $150.15.
Its 50-day moving average was $129.46 and 200-day moving average was $129.3 The short ratio stood at 1.89 indicating a short percent outstanding of 0%.
Around 10.4% of the company’s stock are held by insiders while 9028.1% are held by institutions.
Frequently Asked Questions About Zimmer Biomet Holdings Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.